• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺疾病在监测新冠疫情中的前瞻性作用。

Prospective role of thyroid disorders in monitoring COVID-19 pandemic.

作者信息

Kumari Kanchan, Chainy Gagan B N, Subudhi Umakanta

机构信息

CSIR-Institute of Minerals & Materials Technology, Bhubaneswar 751013, Odisha, India.

Department of Molecular Biology, Umea University, Sweden.

出版信息

Heliyon. 2020 Dec;6(12):e05712. doi: 10.1016/j.heliyon.2020.e05712. Epub 2020 Dec 13.

DOI:10.1016/j.heliyon.2020.e05712
PMID:33344794
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7733548/
Abstract

COVID-19 pandemic has affected more than 200 countries and 1.3 million individuals have deceased within eleven months. Intense research on COVID-19 occurrence and prevalence enable us to understand that comorbidities play a crucial role in spread and severity of SARS-CoV-2 infection. Chronic kidney disease, diabetes, respiratory diseases and hypertension are among the various morbidities that are prevalent in symptomatic COVID-19 patients. However, the effect of altered thyroid-driven disorders cannot be ignored. Since thyroid hormone critically coordinate and regulate the major metabolism and biochemical pathways, this review is on the potential role of prevailing thyroid disorders in SARS-CoV-2 infection. Direct link of thyroid hormone with several disorders such as diabetes, vitamin D deficiency, obesity, kidney and liver disorders etc. suggests that the prevailing thyroid conditions may affect SARS-CoV-2 infection. Further, we discuss the oxidative stress-induced aging is associated with the degree of SARS-CoV-2 infection. Importantly, ACE2 protein which facilitates the host-cell entry of SARS-CoV-2 using the spike protein, are highly expressed in individuals with abnormal level of thyroid hormone. Altogether, we report that the malfunction of thyroid hormone synthesis may aggravate SARS-CoV-2 infection and thus monitoring the thyroid hormone may help in understanding the pathogenesis of COVID-19.

摘要

新冠疫情已影响200多个国家,11个月内有130万人死亡。对新冠病毒发生和流行情况的深入研究使我们明白,合并症在严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染的传播和严重程度中起着关键作用。慢性肾病、糖尿病、呼吸系统疾病和高血压是有症状的新冠患者中普遍存在的多种疾病。然而,甲状腺功能紊乱的影响也不容忽视。由于甲状腺激素对主要代谢和生化途径起着关键的协调和调节作用,本综述探讨了常见甲状腺疾病在SARS-CoV-2感染中的潜在作用。甲状腺激素与糖尿病、维生素D缺乏、肥胖、肾脏和肝脏疾病等多种疾病存在直接联系,这表明常见的甲状腺疾病可能会影响SARS-CoV-2感染。此外,我们还讨论了氧化应激诱导的衰老与SARS-CoV-2感染程度的关系。重要的是,利用刺突蛋白促进SARS-CoV-2进入宿主细胞的血管紧张素转换酶2(ACE2)蛋白在甲状腺激素水平异常的个体中高度表达。总之,我们报告甲状腺激素合成功能障碍可能会加重SARS-CoV-2感染,因此监测甲状腺激素可能有助于了解新冠病毒疾病的发病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d047/7750372/b15ef95d97f4/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d047/7750372/4f56294b2917/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d047/7750372/8e6d26b1b6f7/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d047/7750372/9f6180c79e05/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d047/7750372/b15ef95d97f4/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d047/7750372/4f56294b2917/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d047/7750372/8e6d26b1b6f7/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d047/7750372/9f6180c79e05/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d047/7750372/b15ef95d97f4/gr4.jpg

相似文献

1
Prospective role of thyroid disorders in monitoring COVID-19 pandemic.甲状腺疾病在监测新冠疫情中的前瞻性作用。
Heliyon. 2020 Dec;6(12):e05712. doi: 10.1016/j.heliyon.2020.e05712. Epub 2020 Dec 13.
2
Thyroidal Angiotensin-Converting Enzyme 2 Protein Expression and Thyroid Function Tests in Patients with COVID-19: Results from a Retrospective Case Series and a Prospective Cohort Study.2019冠状病毒病患者的甲状腺血管紧张素转换酶2蛋白表达及甲状腺功能检查:一项回顾性病例系列研究和前瞻性队列研究的结果
Thyroid. 2023 Feb;33(2):177-185. doi: 10.1089/thy.2022.0229.
3
Acute Bacterial Hemorrhagic Pyelonephritis in a COVID-19 Patient With a History of Hypothyroidism: A Case Report.一名有甲状腺功能减退病史的新冠肺炎患者发生急性细菌性出血性肾盂肾炎:病例报告
Cureus. 2022 Jan 30;14(1):e21730. doi: 10.7759/cureus.21730. eCollection 2022 Jan.
4
SARS-CoV-2: Emerging Role in the Pathogenesis of Various Thyroid Diseases.严重急性呼吸综合征冠状病毒2(SARS-CoV-2):在各种甲状腺疾病发病机制中的新作用
J Inflamm Res. 2021 Nov 24;14:6191-6221. doi: 10.2147/JIR.S332705. eCollection 2021.
5
Thyroid autoimmunity and SARS-CoV-2 infection: Report of a large Italian series.甲状腺自身免疫与 SARS-CoV-2 感染:一项大型意大利系列研究报告。
Autoimmun Rev. 2022 Nov;21(11):103183. doi: 10.1016/j.autrev.2022.103183. Epub 2022 Aug 23.
6
Insights into SARS-CoV-2-associated subacute thyroiditis: from infection to vaccine.SARS-CoV-2 相关亚急性甲状腺炎的研究进展:从感染到疫苗。
Virol J. 2023 Jun 21;20(1):132. doi: 10.1186/s12985-023-02103-1.
7
Covid-19, the thyroid and the pituitary - The real state of play.Covid-19、甲状腺和垂体——真实的情况。
Ann Endocrinol (Paris). 2022 Apr;83(2):103-108. doi: 10.1016/j.ando.2021.12.004. Epub 2022 Jan 20.
8
Susceptibilities of Human ACE2 Genetic Variants in Coronavirus Infection.人类 ACE2 基因变异体对冠状病毒感染的易感性。
J Virol. 2022 Jan 12;96(1):e0149221. doi: 10.1128/JVI.01492-21. Epub 2021 Oct 20.
9
An improved Fuzzy based GWO algorithm for predicting the potential host receptor of COVID-19 infection.基于改进的模糊灰狼优化算法预测 COVID-19 感染的潜在宿主受体。
Comput Biol Med. 2022 Dec;151(Pt A):106050. doi: 10.1016/j.compbiomed.2022.106050. Epub 2022 Aug 25.
10
Strong Association of Angiotensin Converting Enzyme-2 Gene Insertion/Deletion Polymorphism with Susceptibility to SARS-CoV-2, Hypertension, Coronary Artery Disease and COVID-19 Disease Mortality.血管紧张素转换酶2基因插入/缺失多态性与对严重急性呼吸综合征冠状病毒2的易感性、高血压、冠状动脉疾病及2019冠状病毒病死亡率的强关联
J Pers Med. 2021 Oct 27;11(11):1098. doi: 10.3390/jpm11111098.

引用本文的文献

1
The Prognostic Properties of Thyroid Disorders, Hypothyroidism, and Hyperthyroidism in Predicting COVID-19 Poor Outcomes: A Systematic Review and Diagnostic Meta-analysis.甲状腺疾病、甲状腺功能减退和甲状腺功能亢进在预测COVID-19不良结局中的预后特性:一项系统评价和诊断性荟萃分析
Indian J Endocrinol Metab. 2022 Nov-Dec;26(6):510-517. doi: 10.4103/ijem.ijem_20_22. Epub 2022 Dec 20.
2
The Multisystem Impact of Long COVID: A Comprehensive Review.长新冠的多系统影响:全面综述
Diagnostics (Basel). 2024 Jan 24;14(3):244. doi: 10.3390/diagnostics14030244.
3
Polygenic regression uncovers trait-relevant cellular contexts through pathway activation transformation of single-cell RNA sequencing data.

本文引用的文献

1
Thyroid Function Abnormalities in COVID-19 Patients.新型冠状病毒肺炎患者甲状腺功能异常。
Front Endocrinol (Lausanne). 2021 Feb 19;11:623792. doi: 10.3389/fendo.2020.623792. eCollection 2020.
2
Coronavirus infection and PARP expression dysregulate the NAD metabolome: An actionable component of innate immunity.冠状病毒感染和 PARP 表达失调 NAD 代谢组:先天免疫的一个可操作成分。
J Biol Chem. 2020 Dec 25;295(52):17986-17996. doi: 10.1074/jbc.RA120.015138. Epub 2020 Oct 13.
3
Focus on uncommon symptoms of COVID-19: Potential reason for spread of infection.
多基因回归通过单细胞RNA测序数据的通路激活转化揭示与性状相关的细胞环境。
Cell Genom. 2023 Aug 18;3(9):100383. doi: 10.1016/j.xgen.2023.100383. eCollection 2023 Sep 13.
4
Endocrinological Involvement in Children and Adolescents Affected by COVID-19: A Narrative Review.新型冠状病毒肺炎(COVID-19)对儿童和青少年内分泌系统的影响:一篇叙述性综述
J Clin Med. 2023 Aug 11;12(16):5248. doi: 10.3390/jcm12165248.
5
COVID-19 associated thyroid dysfunction and other comorbidities and its management using phytochemical-based therapeutics: a natural way.COVID-19 相关甲状腺功能障碍及其他合并症及其基于植物化学物质的治疗管理:一种自然途径。
Biosci Rep. 2023 Jul 26;43(7). doi: 10.1042/BSR20230293.
6
The Influence of SARS-CoV-2 Infection on the Thyroid Gland.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染对甲状腺的影响。
Biomedicines. 2023 Feb 18;11(2):614. doi: 10.3390/biomedicines11020614.
7
SARS-CoV-2 infection and multi-organ system damage: A review.SARS-CoV-2 感染与多器官系统损伤:综述。
Biomol Biomed. 2023 Feb 1;23(1):37-52. doi: 10.17305/bjbms.2022.7762.
8
Symptomatic Bradycardia Manifesting as Acute Hypothyroidism Following COVID-19 Infection: A Case Report.新冠病毒感染后表现为急性甲状腺功能减退的症状性心动过缓:一例报告
Cureus. 2022 Jul 31;14(7):e27533. doi: 10.7759/cureus.27533. eCollection 2022 Jul.
9
SARS-CoV-2 infection may enhance the adverse effect of thyroid disturbance on climacteric symptoms.新型冠状病毒感染可能会增强甲状腺功能紊乱对更年期症状的不良影响。
J Diabetes Metab Disord. 2022 Jul 24;21(2):2005-2006. doi: 10.1007/s40200-021-00926-9. eCollection 2022 Dec.
10
The prognostic values of thyroid disorders in predicting COVID-19 composite poor outcomes: A systematic review and meta-analysis.甲状腺疾病对预测 COVID-19 复合不良结局的预后价值:系统评价和荟萃分析。
Diabetes Metab Syndr. 2022 May;16(5):102464. doi: 10.1016/j.dsx.2022.102464. Epub 2022 Mar 18.
关注 COVID-19 的不常见症状:感染传播的潜在原因。
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1873-1874. doi: 10.1016/j.dsx.2020.09.017. Epub 2020 Sep 16.
4
COVID-19: Pharmacology and kinetics of viral clearance.新型冠状病毒肺炎:病毒清除的药理学和动力学。
Pharmacol Res. 2020 Nov;161:105114. doi: 10.1016/j.phrs.2020.105114. Epub 2020 Aug 3.
5
The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19.免疫系统作为 SARS-CoV-2 治疗靶点:COVID-19 免疫疗法的系统评价。
Life Sci. 2020 Oct 1;258:118185. doi: 10.1016/j.lfs.2020.118185. Epub 2020 Aug 1.
6
Single-Cell RNA Expression Profiling of ACE2, the Receptor of SARS-CoV-2.新型冠状病毒(SARS-CoV-2)受体ACE2的单细胞RNA表达谱分析
Am J Respir Crit Care Med. 2020 Sep 1;202(5):756-759. doi: 10.1164/rccm.202001-0179LE.
7
Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic intervention.在老年人群中,活性氧作为对SARS-CoV-2产生毒性固有免疫反应的引发剂,可考虑将N-乙酰半胱氨酸作为早期治疗干预措施。
Toxicol Rep. 2020 Jun 18;7:768-771. doi: 10.1016/j.toxrep.2020.06.003. eCollection 2020.
8
Thyroid Function Analysis in 50 Patients with COVID-19: A Retrospective Study.50 例 COVID-19 患者甲状腺功能分析:一项回顾性研究。
Thyroid. 2021 Jan;31(1):8-11. doi: 10.1089/thy.2020.0363. Epub 2020 Jul 10.
9
Identification of Symptoms Prognostic of COVID-19 Severity: Multivariate Data Analysis of a Case Series in Henan Province.新冠病毒病严重程度的症状预后识别:河南省一组病例的多变量数据分析
J Med Internet Res. 2020 Jun 30;22(6):e19636. doi: 10.2196/19636.
10
COVID-19 infection and oxidative stress: an under-explored approach for prevention and treatment?新型冠状病毒肺炎感染与氧化应激:一种尚未充分探索的预防和治疗方法?
Pan Afr Med J. 2020 Apr 29;35(Suppl 2):12. doi: 10.11604/pamj.2020.35.2.22877. eCollection 2020.